SCHEMBL17523328

SCHEMBL17523328

Cc1ccc2[nH]c3c(C=O)c4c(cc3c2c1)[nH]c1ccc(O)cc14

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.54
MAPT P10636 1/20 0.54
AHR P35869 1/20 0.54
KMT2A Q03164 1/20 0.54
WEE1 P30291 7/20 0.48
CHEK1 O14757 8/20 0.45
ROCK2 O75116 1/20 0.43
CDK5 Q00535 2/20 0.42
DYRK1A Q13627 2/20 0.42
CDK5R1 Q15078 2/20 0.42
TOP1 P11387 1/20 0.42
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
KIT P10721 2/20 0.42
PDGFRA P16234 2/20 0.42
FGFR3 P22607 2/20 0.42
BCHE P06276 2/20 0.41
ACHE P22303 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17523329 0.88 MEN1 (0.49) MEN1MAPTAHRKMT2AWEE1
SCHEMBL17523327 0.83 MEN1 (0.55) MEN1MAPTAHRKMT2ACHEK1
SCHEMBL21479976 0.78 AHR (0.65) MEN1MAPTAHRKMT2AROCK2
Glycozolinine SCHEMBL29233385 0.78 ACHE (0.55) MEN1MAPTKMT2AWEE1CHEK1
SCHEMBL17523326 0.74 AHR (0.67) MEN1MAPTAHRKMT2A
SCHEMBL29440653 0.71 AHR (1.00) MEN1MAPTAHRKMT2ACHEK1
SCHEMBL528520 0.71 AHR (1.00) MEN1MAPTAHRKMT2ACHEK1
SCHEMBL29951087 0.70 GAA (0.54) MEN1KMT2AROCK2CDK5DYRK1A
SCHEMBL19045151 0.70 KIF11 (0.59) MEN1MAPTKMT2AWEE1BCHE
SCHEMBL20434637 0.70 KIF11 (0.64) MEN1KMT2AWEE1CHEK1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160039754-A1 SYNTHESIS OF DIINDOLYLMETHANES AND INDOLO[3,2-B]CARBAZOLES, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039754-A1 SYNTHESIS OF DIINDOLYLMETHANES AND INDOLO[3,2-B]CARBAZOLES, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLP1R, GIPR, INSR MEN1 986/4885MAPT 2723/4885AHR 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.